title: Arginine 199 and leucine 208 have key roles in the control of adenosine A2A receptor signalling function.
abstract: One successful approach to obtaining high-resolution crystal structures of G-protein coupled receptors is the introduction of thermostabilising mutations within the receptor. This technique allows the generation of receptor constructs stabilised into different conformations suitable for structural studies. Previously, we functionally characterised a number of mutants of the adenosine A2A receptor, thermostabilised either in an agonist or antagonist conformation, using a yeast cell growth assay and demonstrated that there is a correlation between thermostability and loss of constitutive activity. Here we report the functional characterisation of 30 mutants intermediate between the Rag23 (agonist conformation mutant) and the wild-type receptor using the same yeast signalling assay with the aim of gaining greater insight into the role individual amino acids have in receptor function. The data showed that R199 and L208 have important roles in receptor function; substituting either of these residues for alanine abolishes constitutive activity. In addition, the R199A mutation markedly reduces receptor potency while L208A reduces receptor efficacy. A184L and L272A mutations also reduce constitutive activity and potency although to a lesser extent than the R199A and L208A. In contrast, the F79A mutation increases constitutive activity, potency and efficacy of the receptor. These findings shed new light on the role individual residues have on stability of the receptor and also provide some clues as to the regions of the protein responsible for constitutive activity. Furthermore, the available adenosine A2A receptor structures have allowed us to put our findings into a structural context.
authors.affiliation: Department of Life Sciences, Imperial College London, London, United Kingdom.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Bertheleme
authors.affiliation: Department of Life Sciences, Imperial College London, London, United Kingdom.
authors.forename: Annette
authors.initials: A
authors.lastname: Strege
authors.affiliation: Department of Life Sciences, Imperial College London, London, United Kingdom.
authors.forename: Sorrel E
authors.initials: SE
authors.lastname: Bunting
authors.affiliation: Department of Molecular Discovery Research, GlaxoSmithKline, Hertfordshire, United Kingdom.
authors.forename: Simon J
authors.initials: SJ
authors.lastname: Dowell
authors.affiliation: Department of Life Sciences, Imperial College London, London, United Kingdom.
authors.forename: Bernadette
authors.initials: B
authors.lastname: Byrne
mesh_terms: D001120:Arginine / Q000235:genetics / Q000502:physiology*; D007930:Leucine / Q000235:genetics / Q000502:physiology*; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D043705:Receptor, Adenosine A2A / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D015003:Yeasts / Q000378:metabolism
chemical_list: D043705:Receptor, Adenosine A2A; D001120:Arginine; D007930:Leucine